Samuel M Meier-Menches
Overview
Explore the profile of Samuel M Meier-Menches including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
551
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Outla Z, Oyman-Eyrilmez G, Korelova K, Prechova M, Frick L, Sarnova L, et al.
Elife
. 2025 Mar;
13.
PMID: 40052672
The most common primary malignancy of the liver, hepatocellular carcinoma (HCC), is a heterogeneous tumor entity with high metastatic potential and complex pathophysiology. Increasing evidence suggests that tissue mechanics plays...
2.
Bolliger M, Wasinger D, Brunmair J, Hagn G, Wolf M, Preindl K, et al.
EPMA J
. 2025 Feb;
16(1):165-182.
PMID: 39991101
Objective: Metabolomics measurements of eccrine sweat may provide novel and relevant biomedical information to support predictive, preventive and personalised medicine (3PM). However, only limited data is available regarding metabolic alterations...
3.
Bortel P, Hagn G, Skos L, Bileck A, Paulitschke V, Paulitschke P, et al.
Proc Natl Acad Sci U S A
. 2024 Jul;
121(29):e2313851121.
PMID: 38976734
Mass spectrometry-based omics technologies are increasingly used in perturbation studies to map drug effects to biological pathways by identifying significant molecular events. Significance is influenced by fold change and variation...
4.
Pai V, Bileck A, Hommer N, Janku P, Lindner T, Kauer V, et al.
Sci Rep
. 2024 Apr;
14(1):8395.
PMID: 38600099
The aim of the present study was to investigate retinal microcirculatory and functional metabolic changes in patients after they had recovered from a moderate to severe acute COVID-19 infection. Retinal...
5.
Hagn G, Meier-Menches S, Plessl-Walder G, Mitra G, Mohr T, Preindl K, et al.
J Proteome Res
. 2024 Mar;
23(8):3064-3075.
PMID: 38520676
Metabolomics is an emerging and powerful bioanalytical method supporting clinical investigations. Serum and plasma are commonly used without rational prioritization. Serum is collected after blood coagulation, a complex biochemical process...
6.
Neuditschko B, Legin A, Baier D, Schintlmeister A, Reipert S, Wagner M, et al.
Angew Chem Weinheim Bergstr Ger
. 2024 Mar;
133(10):5121-5126.
PMID: 38505777
No abstract available.
7.
Long D, Eade L, Sullivan M, Dost K, Meier-Menches S, Goldstone D, et al.
J Cheminform
. 2024 Feb;
16(1):15.
PMID: 38321500
Mass spectrometry (MS) is an analytical technique for molecule identification that can be used for investigating protein-metal complex interactions. Once the MS data is collected, the mass spectra are usually...
8.
Baier D, Mendrina T, Schoenhacker-Alte B, Pirker C, Mohr T, Rusz M, et al.
Adv Sci (Weinh)
. 2023 Sep;
10(32):e2301939.
PMID: 37752764
The leading first-in-class ruthenium-complex BOLD-100 currently undergoes clinical phase-II anticancer evaluation. Recently, BOLD-100 is identified as anti-Warburg compound. The present study shows that also deregulated lipid metabolism parameters characterize acquired...
9.
Borutzki Y, Skos L, Gerner C, Meier-Menches S
Chembiochem
. 2023 Jun;
24(17):e202300178.
PMID: 37345897
During recent years, accumulating evidence suggested that metal-based candidate drugs are promising modulators of cytoskeletal and cytoskeleton-associated proteins. This was substantiated by the identification and validation of actin, vimentin and...
10.
Janker L, Schuster D, Bortel P, Hagn G, Meier-Menches S, Mohr T, et al.
J Crohns Colitis
. 2023 Mar;
17(9):1514-1527.
PMID: 36961872
Introduction: Ulcerative colitis [UC] is a chronic disease with rising incidence and unclear aetiology. Deep molecular phenotyping by multiomics analyses may provide novel insights into disease processes and characteristic features...